Emerging nations 'will push drug spending above $1trn'

Global spending on pharmaceuticals is expected to break through the $1trillion (£650bn) barrier over the next five years as demand from emerging economies surges, research shows.

Drug sales are expected to grow at between 5 and 8 per cent per year until 2014, taking the total spent to $1.1trn, according to IMS Health, a healthcare industry intelligence group.

Established drugs losing their patent protection in the developing world, combined with stronger demand from these countries, will push up sales by nearly $300bn a year, the group said.

"Patient demand for pharmaceuticals will remain robust, despite the ongoing effects of the downturn being felt in many parts of the world," said Murray Aitken, a senior vice-president at IMS Health. "In developed markets with publicly funding healthcare plans, pressure by payers to curb drug spending will only intensify, but that will be more than offset by the ongoing, rapid expansion of demand in the emerging markets".

IMS expects drug sales in developing nations to grow at between 14 and 17 per cent over the next five years, overshadowing Western markets that will expand at between just 3 and 6 per cent. Despite this surge in emerging economies, IMS Health predicts that the US will continue to be the world's biggest market for healthcare, with a spend of $390bn by 2014.

Forecasts of stronger growth will come as welcome relief to the giants of the pharmaceuticals industry. Companies such as GlaxoSmithKline and AstraZeneca have reported stiffer competition in recent years from makers of generic drugs, who increasingly have used the courts to challenge the patents owned by the majors.

By 2014, drugs whose sales currently total $142bn will face new competition from cheaper generics, according to IMS. In the US, six blockbuster drugs will lose their patent protection by 2012, including GSK's asthma treatment, Advair, and Pfizer's anti-cholesterol pill, Lipitor. GSK and AstraZeneca have ramped up their efforts in emerging markets. David Brennan, the chief executive of AstraZeneca, said recently: "There is no denying the scale of the opportunity these markets present but, like anything else in this industry, it takes a sound strategy and excellent execution." Yesterday, the company said: "Everyone points to population growth in emerging markets, but what is as important is the rising demand driven by increasing middle classes."

Despite the predictions of strong growth, 2010 will see a temporary slowdown. The global market is expected to expand by between 4 and 6 per cent this year – compared with 7 per cent growth last year, when the market was worth $837bn. In 2008, the industry grew by 4.8 per cent.

IMS Health said this year's falls would be triggered by tighter price controls imposed by European governments. It also predicted that certain therapy areas were likely to lead international growth. Its report added: "As pharmaceutical industry research and development programmes adjust to the broad availability of low-cost generic options in many chronic therapy areas, higher growth will occur in those therapy areas where there is significant, unmet clinical need."

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Ashdown Group: Treasury Assistant - Accounts Assistant - London, Old Street

£24000 - £26000 per annum + benefits : Ashdown Group: A highly successful, glo...

Ashdown Group: Business Analyst - Financial Services - City, London

£50000 - £55000 per annum: Ashdown Group: Business Analyst - Financial Service...

SThree: Trainee Recruitment Consultant

£18000 - £23000 per annum + OTE £45K: SThree: At SThree, we like to be differe...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + competitive: SThree: Did you know? SThree is the o...

Day In a Page

General Election 2015: Chuka Umunna on the benefits of immigration, humility – and his leader Ed Miliband

Chuka Umunna: A virus of racism runs through Ukip

The shadow business secretary on the benefits of immigration, humility – and his leader Ed Miliband
Yemen crisis: This exotic war will soon become Europe's problem

Yemen's exotic war will soon affect Europe

Terrorism and boatloads of desperate migrants will be the outcome of the Saudi air campaign, says Patrick Cockburn
Marginal Streets project aims to document voters in the run-up to the General Election

Marginal Streets project documents voters

Independent photographers Joseph Fox and Orlando Gili are uploading two portraits of constituents to their website for each day of the campaign
Game of Thrones: Visit the real-life kingdom of Westeros to see where violent history ends and telly tourism begins

The real-life kingdom of Westeros

Is there something a little uncomfortable about Game of Thrones shooting in Northern Ireland?
How to survive a social-media mauling, by the tough women of Twitter

How to survive a Twitter mauling

Mary Beard, Caroline Criado-Perez, Louise Mensch, Bunny La Roche and Courtney Barrasford reveal how to trounce the trolls
Gallipoli centenary: At dawn, the young remember the young who perished in one of the First World War's bloodiest battles

At dawn, the young remember the young

A century ago, soldiers of the Empire – many no more than boys – spilt on to Gallipoli’s beaches. On this 100th Anzac Day, there are personal, poetic tributes to their sacrifice
Dissent is slowly building against the billions spent on presidential campaigns – even among politicians themselves

Follow the money as never before

Dissent is slowly building against the billions spent on presidential campaigns – even among politicians themselves, reports Rupert Cornwell
Samuel West interview: The actor and director on austerity, unionisation, and not mentioning his famous parents

Samuel West interview

The actor and director on austerity, unionisation, and not mentioning his famous parents
General Election 2015: Imagine if the leading political parties were fashion labels

Imagine if the leading political parties were fashion labels

Fashion editor, Alexander Fury, on what the leaders' appearances tell us about them
Phumzile Mlambo-Ngcuka: Home can be the unsafest place for women

Phumzile Mlambo-Ngcuka: Home can be the unsafest place for women

The architect of the HeForShe movement and head of UN Women on the world's failure to combat domestic violence
Public relations as 'art'? Surely not

Confessions of a former PR man

The 'art' of public relations is being celebrated by the V&A museum, triggering some happy memories for DJ Taylor
Bill Granger recipes: Our chef succumbs to his sugar cravings with super-luxurious sweet treats

Bill Granger's luxurious sweet treats

Our chef loves to stop for 30 minutes to catch up on the day's gossip, while nibbling on something sweet
London Marathon 2015: Paula Radcliffe and the mother of all goodbyes

The mother of all goodbyes

Paula Radcliffe's farewell to the London Marathon will be a family affair
Everton vs Manchester United: Steven Naismith demands 'better' if Toffees are to upset the odds against United

Steven Naismith: 'We know we must do better'

The Everton forward explains the reasons behind club's decline this season
Arsenal vs Chelsea: Praise to Arsene Wenger for having the courage of his convictions

Michael Calvin's Last Word

Praise to Wenger for having the courage of his convictions